Month: February 2017

Nippon Shokubai starts mass production trial of graphene oxide materials

NEDO forecasts that the market size of graphene material in 2030 will be about 100 billion yen. Under a NEDO contract, Nippon Shokubai has initiated experiments on mass production of graphene oxide. Graphene oxide is a flake-like material with a thickness of 1 nm with unprecedented characteristics (e. g., conductivity, hydrophilicity, dispersibility) which can be […]

NSG Group (Nippon Sheet Glass) and AIST develop hand-held DNA test device which detects bacteria and viruses on-site in 10 min

AIST focused on a micro flow channel made from thin and small plastic substrate, inserted between high temperature and low temperature regions. The genes are amplified by moving the sample at high speed and detecting with fluorescence. Nippon Sheet Glass has developed a compact fluorescence detector that utilizes the technology of SELFOC® microlens used for […]

RIKEN and Kobe Hospital recruit additional patients for clinical studies on age-related macular degeneration (AMD)

The clinical study will be led by Mr Yasuo KURIMOTO, Director of Ophtalmology at Kobe City Medical Center, and Mrs Masayo TAKAHASHI of RIKEN. In the study, a suspension of retinal pigment epithelium (RPE) cells derived from other iPS cells will be transplanted. The patients will be between 50 and 85 years old. RIKEN CDB […]

NEDO consortium develops flexible sheet sensor which realizes sensations close to human skin

The makeup consists of a pattern of pressure sensitive and temperature sensitive layers on a printed flexible array sheet, arranging the pressure sensitive portions and the temperature sensitive portions at high density. The prototype sheet sensor has a thickness of about 0.3 mm and high flexibility. Detection area is 173 × 260 mm2 and contains […]

CiRA, Dainippon Sumitomo Pharma and Hitachi prepare for clinical trial on iPS-cell-derived dopamine neural progenitor cells

Jointly with Prof. Atsushi TAKAHASHI of CiRA, DSP and Hitachi have initiated experiments on the mass-production of dopamine neural progenitor cells derived from iPS cells and are preparing for doctor-initiated clinical trial on treatment for Parkinson’s disease in 2018. Dainippon Sumitomo Pharma news release, July 24, 2015; Nikkei Biotech news release, February 6, 2017

ATR develops „dialog robot“ which facilitates conversation with robots

The project entrusted to the International Telecommunications Research Institute will attempt to use cerebral blood flow data, measured by a near infra-red system, in a test person as an indicator to optimize man-machine conversation. Increased cerebral blood flow rate indicates that a person has difficulties in understanding a robot’s speech, permitting the robot to change […]

Kagome will label tomato juice products with health claim, expects 1.7 fold higher sales

This step concerns three Kagome vegetable juices” that have been on sale since 1973. According to the Consumer Agency’s new system on functionality presentation, the products will now be labelled as useful “to those with increased blood pressure” (lycopene-based lowering of cholesterol level). The sales target from May 2017 to December 2017 is 990 million […]

NAIST team develops one-pot synthesis for organosilicon materials

A research team around Shigeru SHIMADA has developed a one-pot three-step catalytic system for the synthesis of siloxanes. The three catalytic reactions are hydrosilylation of silyl ester with iridium catalyst, rearrangement reaction by a boron catalyst, and decarbonylation-condensation by a boron catalyst. It is expected that this procedure responds to the needs to develop precisely […]

Scroll to top